Liquidia reports 31% increase in Q3 net product revenue and completes litigation settlement
LQDA Liquidia Corp
$51.40 +7.37%
View chart & analysis → - 1Liquidia recorded a 31% sequential increase in net product revenue for Q3 2026.
- 2Liquidia finalized a global settlement to resolve a multi-year litigation with United Therapeutics.
- 3Liquidia ended Q3 2026 with $396.1 million in cash on hand.
So what's the key point?
Liquidia's revenue from product sales grew by 31 percent compared to the previous quarter. The company also resolved its legal issues and maintains a healthy cash balance.
Source The Motley Fool +1 · View original ↗
Nothing hidden: past picks and how they did against the S&P 500.